National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 88788 [2024-25936]
Download as PDF
<![CDATA[
88788
Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before December 9, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 264–0041, or PRA@HHS.GOV.
When submitting comments or
requesting information, please include
the document identifier 0990–New–30D
and project title for reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
SUMMARY:
collection of performance-oriented data
tied to OMH-wide performance
reporting needs. The ability to monitor
and evaluate performance in this
manner, and to work towards
continuous program improvement are
basic functions that OMH must be able
to accomplish to carry out its mandate
with the most effective and appropriate
use of resources.
This information collection includes
two new web-based data collection
tools:
• OMH Performance Progress Report
• Disparity Impact Statement
The OMH Performance Progress
Report is a supplement to the Office of
the Assistant Secretary for Health
(OASH) periodic Performance Progress
Report, and recipients will submit
reports on a quarterly basis. Recipients
will submit the Disparity Impact
Statement once during the period of
performance.
Likely Respondents: Members and
staff from academia, community
organizations, private non-profit
organizations, local/state/federal
government, and tribal government and
services organizations including those
who serve American Indian and Alaska
Native and/or racial and ethnic
minorities.
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Performance
and Evaluation Measurement System
(PEMS).
Type of Collection: New Data
Collection.
OMB No. 0990–NEW.
Abstract: The U.S. Department of
Health and Human Services (HHS)
Office of Minority Health (OMH) is
requesting OMB approval on a new
information collection, Performance and
Evaluation Measurement System
(PEMS). The proposed information
collection activity will allow OMH to
collect grant management and
performance data and disparity impact
information for all OMH-funded
projects. The clearance is needed to
support data collection using Grant
Solutions, a system that enables OMH to
comply with Federal reporting
requirements and monitor and evaluate
performance by enabling the efficient
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
responses per
respondent
OMH grant recipients—Disparity Impact Statement ........................................
OMH grant recipients—OMH Performance Progress Report .........................
125
125
1
4
1
1.5
125
750
Total ..........................................................................................................
250
5
2.5
875
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2024–26057 Filed 11–7–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number
of respondents
Type of respondent
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
17:38 Nov 07, 2024
Jkt 265001
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Limited Interaction Targeted
Epidemiology: Epidemiology of Transmission
and Treatment of HIV Among People Who
Are at Increased Risk for HIV Infection in
Latin America (LITE–LA) (UG3/UH3 Clinical
Trial Optional).
Date: December 3, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00092
Fmt 4703
Sfmt 9990
Total burden
hours
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F40,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F40, Rockville, MD
20892 240–669–5035, unferrc@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–25936 Filed 11–7–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Page 88788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25936]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Limited Interaction Targeted
Epidemiology: Epidemiology of Transmission and Treatment of HIV
Among People Who Are at Increased Risk for HIV Infection in Latin
America (LITE-LA) (UG3/UH3 Clinical Trial Optional).
Date: December 3, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F40,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Robert C. Unfer, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F40,
Rockville, MD 20892 240-669-5035, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-25936 Filed 11-7-24; 8:45 am]
BILLING CODE 4140-01-P
